PABLO
ROJO CONEJO
Profesor asociado de Ciencias de la Salud
MRC Clinical Trials Unit
Londres, Reino UnidoPublications en collaboration avec des chercheurs de MRC Clinical Trials Unit (3)
2021
2017
2011
-
First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: An open-label, randomised phase 2/3 trial
The Lancet Infectious Diseases, Vol. 11, Núm. 4, pp. 273-283